European Journal of Clinical Pharmacology

, Volume 12, Issue 6, pp 397–402 | Cite as

Haemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol

  • C. L. A. van Herwaarden
  • J. F. M. Fennis
  • R. A. Binkhorst
  • A. van 't Laar


A double blind cross-over trial of propranolol and metoprolol was carried out in eight hypertensive patients. At the end of each four-week period of medication, blood pressure and heart rate at rest were measured, and the haemodynamic effects of adrenaline infusion were studied. At rest, propranolol and metroprolol reduced the blood pressure and pulse rate to the same degree. Adrenaline infusion during propranolol medication caused a marked increase both in systolic and diastolic blood pressure, the blood flow in the forearm was unchanged, and the calculated vascular resistance showed a marked increase. Adrenaline infusion during metoprolol medication caused a less marked increase in systolic blood pressure and the diastolic pressure remained unchanged. Blood flow in the forearm increased and the vascular resistance in the forearm tended to decrease. Adrenaline infusion, therefore, caused different haemodynamic effects during non-selective β-blockade with propranolol and during β1-selective blockade with metoprolol. It seems probable that the adrenaline infusion test is comparable with adrenaline release during stress situations and the results may indicate that a β1-selective blocker is to be preferred to a non-selective one as a therapeutic agent in the treatment of hypertension.

Key words

β-Blockade β1-selectivity propranolol metoprolol adrenaline haemodynamic effects treatment of hypertension 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bengtsson, C.: Comparison between metoprolol and propranolol as antihypertensive agents. Acta med. scand.199, 71–74 (1976)Google Scholar
  2. Blum, J., Atsmon, A., Steiner M., Wysenbeek H.: Paradoxical rise in blood pressure during propranolol treatment. Brit. med. J.1975/I, 623Google Scholar
  3. Brakkee, A.J.M., Vendrik, A.J.H.: Strain-gauge plethysmography; theoretical and practical notes on a new design. J. appl. Physiol.21, 701–704 (1966)Google Scholar
  4. Brick, I., Hutchison, K.J., McDevitt, D.G., Roddie, I.C., Shanks, R.G.: Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. Brit. J. Pharmacol.34, 127–140 (1968)Google Scholar
  5. Brod, J., Cachovan, M., Bahlmann, J., Bauer, G.E., Celsen, B., Sippel, R., Hundeshagen, H., Feldman, U., Rienhoff, O.: Haemodynamic response to an acute emotional stress (mental arithmetic) with special reference to the venous side. Aust. N.Z.J. Med.6, suppl. 2, 19–25 (1976)Google Scholar
  6. Carlsson, E., Åblad, B., Brändström, A., Carlsson, B.: Differentiated blockade of the chronotropic effects of various adrenergic stimuli in the cat heart. Life Sci.11, 953–958 (1972)Google Scholar
  7. Davidson, C., Thadani, U., Singleton, W., Taylor, S.H.: Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment. Brit. med. J.1976/II, 7–9Google Scholar
  8. Gillam, P.M.S., Prichard, B.N.C.: Discovery of the hypothesive effect of propranolol. Postgrad. med. J.52, suppl. 4, 70–75 (1976)Google Scholar
  9. Hansson, L., Zweifler, A.J., Julius, S., Hunyor, S.N.: Hemodynamic effects of acute and prolonged β-adrenergic blockade in essential hypertension. Acta med. scand.196, 27–34 (1974)Google Scholar
  10. Johnsson, G.: Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work. Acta pharmacol. toxicol.36, suppl. 5, 59–68 (1975)Google Scholar
  11. Johnsson, G., Nyberg, G., Sölvell, L.: Influence of metoprolol and propranolol on hemodynamic effects induced by physical work and isoprenaline. Acta pharmacol. toxicol.36, suppl. 5, 69–75 (1975)Google Scholar
  12. Lands, A.M., Arnold, A., McAuliff, J.P., Luduena, F.P., Brown, T.G. jun.: Differentiation of receptor systems activated by sympathomimetic amines. Nature214, 597–598 (1967)Google Scholar
  13. Levi, L.: Sympathoadrenomedullary responses to “pleasant” and “unpleasant” psychosocial stimuli. Acta med. scand.191, suppl. 528, 55–73 (1972)Google Scholar
  14. Lloyd-Mostyn, R.H., Oram, S.: Modification by propranolol of cardiovascular effects of induced hypoglycaemia. Lancet1975/I, 1213–1215Google Scholar
  15. Tarazi, R.C., Dustan, H.P.: Beta-adrenergic blockade in hypertension. Practical and theoretical implications of longterm hemodynamic variation. Amer. J. Cardiol.29, 633–640 (1972)Google Scholar
  16. Zacharias, F.J., Cowen, K.J.: Controlled trial of propranolol in hypertension. Brit. med. J.1970/I, 471–474Google Scholar

Copyright information

© Springer-Verlag 1977

Authors and Affiliations

  • C. L. A. van Herwaarden
    • 1
    • 3
  • J. F. M. Fennis
    • 1
  • R. A. Binkhorst
    • 2
  • A. van 't Laar
    • 1
  1. 1.Department of MedicineOut-patient ClinicNijmegenThe Netherlands
  2. 2.Section for Physiology of Exercise, Laboratory of PhysiologyUniversity of NijmegenNijmegenThe Netherlands
  3. 3.St. Radboud ZiekenhuisNijmegenHolland

Personalised recommendations